© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Daptomycin carries a big reputation in the antibiotics world, showing up as a cyclic lipopeptide antimicrobial agent that targets tough Gram-positive bacteria. The appeal comes from its ability to punch through cell membranes, messing with essential processes and leading to bacterial death. It’s not something people pick up at a drugstore for a run-of-the-mill infection; its design tailors it for serious, sometimes drug-resistant infections. Those in the field often admire daptomycin’s story, which began in soil, thanks to the actinomycete Streptomyces roseosporus. For folks in the business of pharmaceuticals, knowledge about a compound's story matters—knowing where something originates, the raw materials used to make it—these facts build trust and ensure safe handling along every step.
A quick glance at pure daptomycin in the lab offers a few solid clues to its nature. Most of the time it arrives as a pale yellow to light brown solid, sometimes taking shape as powder, flakes, or crystalline material. Pop it into a solution, and it dissolves well in water, a key point for hospital settings that need a drug ready for IV infusion. The compound has a molecular formula of C72H101N17O26—a complex architecture reflecting its biological role. Its molar mass falls about 1,619.7 g/mol, making it a heavyweight in the chemical world compared to everyday small molecules. Density varies depending on whether it’s solid, hydrated, or part of a concentrate. Technical sheets cite a value close to 1.36 g/cm3, but real measurements often depend on particular batches and the degree of hydration.
Daptomycin ships out of manufacturing plants as a raw material in several forms: powder, crystalline flakes, sometimes as lyophilized pearls, each meant for different stages of the supply chain. Powder works for precise measurement and reconstitution for pharmaceutical preparations. Flakes, though less common, play a role when storage and reconstitution strategies need it. Daptomycin as a solution comes pre-measured, ready for medical staff to dilute, sparing critical minutes in a hospital setting. Liquid preparations in bulk rarely leave the manufacturing floor due to reduced stability, with most companies preferring the solid form to extend shelf life. Some materials hold up best under refrigeration, often at 2–8°C, protecting their molecular structure from the havoc of heat or light.
Customs brokers and global logistics professionals know every material moving across borders needs a proper Customs Harmonized System code. Daptomycin crosses borders tagged as HS Code 2941.90, which places it under antibiotics not elsewhere specified or included. Getting this right keeps shipments moving and meets global legal requirements. Anyone in procurement knows a slip-up here brings fines or seized shipments, so attention to detail runs high. Chemical identification also points to its CAS Number (103060-53-3), a detail that helps laboratories, hospitals, and safety regulators match exactly what sits inside every drum, bottle, or vial.
Daptomycin’s benefits don’t erase the need for careful handling. Raw materials in powder or crystalline form may pose inhalation or allergic risks for workers who mix or weigh them. Standard operating procedures usually call for gloves, gowns, and sometimes respirators. Laboratory data point to mild irritation as the main risk for adults. As a large molecule, daptomycin doesn’t cross skin barriers easily and has low volatility, reducing some hazards common to smaller chemicals. That’s not the case for people with allergies to similar molecules or existing sensitivities—one accidental exposure can land someone in trouble.
Waste daptomycin and contaminated materials require strict disposal protocols. Facilities with high-quality Environmental, Health, and Safety (EHS) programs train staff early and often. People sometimes don’t realize long-term, low-level exposure can still create problems, especially for anyone involved in frequent returns or spills in the warehouse. Some regulatory agencies have begun classifying pharmaceutical wastes like daptomycin as hazardous, adding another layer of tracking. This closes loopholes that might allow harmful residues to end up in landfill or water.
One of the few downsides to a powerhouse antimicrobial like daptomycin shows up in its environmental persistence. Trace residues in water have turned up in several global studies. Long-term data remain limited, but some scientists worry about bacteria developing new resistance genes after low-level exposure in the environment. Pharmaceutical companies, wastewater processors, and regulators need to work together on better filtration and neutralization methods to keep daptomycin and compounds like it from spreading unchecked. More research money for advanced water treatment pays dividends for everyone, keeping vital antibiotics potent for use in clinics, not floating in rivers.
Handling pharmaceuticals—especially an agent as powerful and specific as daptomycin—brings constant challenges to balancing safety, efficacy, and staying in line with regulations. Companies aiming to demonstrate responsibility do well sticking with proven material forms, looking after their workers, and reporting up-to-date property and hazard information. Supply chain teams need the proper HS Code and chemical identity down to the letter. Everyone along the chain, from suppliers to labs to clinics, shares in the job of keeping this molecule both effective and safely managed for the long haul.
